Upadacitinib 15 MG
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Assiut University
Overview
Upadacitinib 15 MG is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Upadacitinib 15 MG clinical trials
Explore related
Medical disclaimer. This page summarizes research about Upadacitinib 15 MG for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.